Shanzebio is a specialized platform company dedicated to the introduction and commercialization of innovative pharmaceutical products from around the world.
Our vision is to become a leader in the biopharmaceutical industry, focusing on critical care, anti-infectives, and respiratory diseases; our mission is to safeguard human health through innovation and speed.
Invested by HSG, we focus on anti-infectives, respiratory diseases, and critical care. Through a commercialization model that combines “core product operations with the introduction of innovative pipelines”, we are committed to delivering sustainable medical solutions for patients worldwide.
In the future, we will remain rooted in China while leveraging our proven commercialization model and global operational capabilities to bring cutting-edge innovative products to patients worldwide, further advancing human health.